Anheuser-Busch InBev Analyst Ratings
Anheuser-Busch InBev Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
09/29/2023 | — | B of A Securities | Upgrades | Neutral → Buy | |
07/20/2023 | 23.2% | Morgan Stanley | $64 → $68.5 | Upgrades | Equal-Weight → Overweight |
06/22/2023 | — | Deutsche Bank | Upgrades | Hold → Buy | |
06/08/2023 | 25.9% | Evercore ISI Group | $80 → $70 | Maintains | Outperform |
11/19/2021 | — | Redburn Partners | Upgrades | Neutral → Buy | |
09/30/2021 | — | Argus Research | Downgrades | Buy → Hold | |
09/02/2021 | 2.52% | JP Morgan | → $57 | Downgrades | Neutral → Underweight |
06/18/2021 | 58.27% | Argus Research | $65 → $88 | Maintains | Buy |
10/07/2020 | — | Jefferies | Upgrades | Hold → Buy | |
07/30/2020 | 34.89% | Evercore ISI Group | → $75 | Upgrades | In-Line → Outperform |
05/26/2020 | -10.07% | CFRA | $70 → $50 | Maintains | Hold |
05/20/2020 | -29.86% | JP Morgan | → $39 | Upgrades | Underweight → Neutral |
03/12/2020 | — | RBC Capital | Upgrades | Sector Perform → Outperform | |
03/09/2020 | — | Credit Suisse | Downgrades | Outperform → Neutral | |
03/03/2020 | — | B of A Securities | Downgrades | Buy → Neutral | |
02/28/2020 | — | Bryan Garnier | Downgrades | Buy → Neutral | |
02/26/2020 | — | Goldman Sachs | Initiates Coverage On | → Neutral | |
02/20/2020 | 16.91% | JP Morgan | $79 → $65 | Downgrades | Neutral → Underweight |
11/18/2019 | — | Redburn Partners | Upgrades | Sell → Neutral | |
11/07/2019 | 42.09% | JP Morgan | $94.5 → $79 | Maintains | Neutral |
08/27/2019 | — | Barclays | Downgrades | Equal-Weight → Underweight | |
08/06/2019 | — | UBS | Downgrades | Buy → Neutral | |
07/29/2019 | — | B of A Securities | Upgrades | Neutral → Buy | |
05/30/2019 | — | Argus Research | Upgrades | Hold → Buy | |
04/02/2019 | — | Barclays | Initiates Coverage On | → Equal-Weight | |
03/07/2019 | 34.89% | RBC Capital | → $75 | Downgrades | Top Pick → Sector Perform |
03/01/2019 | 51.08% | Macquarie | $80 → $84 | Maintains | Neutral |
01/22/2019 | — | RBC Capital | Upgrades | Outperform → Top Pick | |
01/16/2019 | — | Jefferies | Downgrades | Hold → Underperform | |
11/12/2018 | — | Argus Research | Downgrades | Buy → Hold | |
10/29/2018 | — | RBC Capital | Upgrades | Sector Perform → Outperform | |
10/01/2018 | — | Jefferies | Downgrades | Buy → Hold |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
09/29/2023 | - | B of A证券 | 升级 | 中性→购买 | |
07/20/2023 | 23.2% | 摩根士丹利 | $64→$68.5 | 升级 | 等重→超重 |
2023/06/22 | - | 德意志银行 | 升级 | 持有→购买 | |
06/08/2023 | 25.9% | Evercore ISI集团 | $80→$70 | 维护 | 跑赢大盘 |
2021年11月19日 | - | Redburn合作伙伴 | 升级 | 中性→购买 | |
09/30/2021 | - | Argus研究 | 评级下调 | 购买→Hold | |
09/02/2021 | 2.52% | 摩根大通 | →$57 | 评级下调 | 中性→减持 |
06/18/2021 | 58.27% | Argus研究 | $65→$88 | 维护 | 买 |
10/07/2020 | - | 杰富瑞 | 升级 | 持有→购买 | |
07/30/2020 | 34.89% | Evercore ISI集团 | →$75 | 升级 | 线内→表现优异 |
05/26/2020 | -10.07% | CFRA | $70→$50 | 维护 | 保持 |
05/20/2020 | -29.86% | 摩根大通 | →$39 | 升级 | 减重→中性 |
03/12/2020 | - | 加拿大皇家银行资本 | 升级 | 行业表现优于→ | |
03/09/2020 | - | 瑞士信贷 | 评级下调 | 跑赢→中性 | |
03/03/2020 | - | B of A证券 | 评级下调 | 购买→中性 | |
02/28/2020 | - | 布莱恩·加尼耶 | 评级下调 | 购买→中性 | |
02/26/2020 | - | 高盛 | 开始承保 | →中性 | |
02/20/2020 | 16.91% | 摩根大通 | $79→$65 | 评级下调 | 中性→减持 |
2019年11月18日 | - | Redburn合作伙伴 | 升级 | 卖出→中性 | |
2019/07/11 | 42.09% | 摩根大通 | $94.5→$79 | 维护 | 中性 |
2019年08月27日 | - | 巴克莱 | 评级下调 | 等重→减码 | |
2019年08月06日 | - | 瑞银集团 | 评级下调 | 购买→中性 | |
2019年07月29日 | - | B of A证券 | 升级 | 中性→购买 | |
2019年05月30日 | - | Argus研究 | 升级 | 持有→购买 | |
2019年02月04日 | - | 巴克莱 | 开始承保 | →等重 | |
2019年07月03日 | 34.89% | 加拿大皇家银行资本 | →$75 | 评级下调 | 最佳→行业表现 |
2019年03月01日 | 51.08% | 麦格理 | $80→$84 | 维护 | 中性 |
2019年01月22日 | - | 加拿大皇家银行资本 | 升级 | 表现优于→最佳选择 | |
2019年01月16日 | - | 杰富瑞 | 评级下调 | 持有→表现不佳 | |
2018年11月12日 | - | Argus研究 | 评级下调 | 购买→Hold | |
2018年10月29日 | - | 加拿大皇家银行资本 | 升级 | 行业表现优于→ | |
10/01/2018 | - | 杰富瑞 | 评级下调 | 购买→Hold |
What is the target price for Anheuser-Busch InBev (BUD)?
百威英博(Bud)的目标价是多少?
The latest price target for Anheuser-Busch InBev (NYSE: BUD) was reported by B of A Securities on September 29, 2023. The analyst firm set a price target for $0.00 expecting BUD to fall to within 12 months (a possible -100.00% downside). 4 analyst firms have reported ratings in the last year.
美国银行证券于2023年9月29日报告了百威英博(纽约证券交易所代码:BUD)的最新目标价。这家分析公司将目标价定为0.00美元,预计Bud将在12个月内下跌(可能下跌100.00%)。去年有4家分析公司公布了评级。
What is the most recent analyst rating for Anheuser-Busch InBev (BUD)?
百威英博(Anheuser-Busch InBev)最近的分析师评级是多少?
The latest analyst rating for Anheuser-Busch InBev (NYSE: BUD) was provided by B of A Securities, and Anheuser-Busch InBev upgraded their buy rating.
百威英博(NYSE:BUD)的最新分析师评级是由美国银行证券提供的,百威英博上调了其买入评级。
When is the next analyst rating going to be posted or updated for Anheuser-Busch InBev (BUD)?
百威英博(Anheuser-Busch InBev)的下一次分析师评级将于何时发布或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Anheuser-Busch InBev, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Anheuser-Busch InBev was filed on September 29, 2023 so you should expect the next rating to be made available sometime around September 29, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公开财务报表,与百威英博的高管和客户交谈,以及收听收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。安海斯-布希啤酒公司的上一次评级是在2023年9月29日提交的,因此你应该预计下一次评级将在2024年9月29日左右的某个时候公布。
Is the Analyst Rating Anheuser-Busch InBev (BUD) correct?
分析师对百威英博的评级正确吗?
While ratings are subjective and will change, the latest Anheuser-Busch InBev (BUD) rating was a upgraded with a price target of $0.00 to $0.00. The current price Anheuser-Busch InBev (BUD) is trading at is $55.60, which is out of the analyst's predicted range.
虽然评级是主观的,而且会发生变化,但最新的安海斯-布希百威英博(Anheuser-Busch InBev)评级被上调,目标价从0.00美元到0.00美元。百威英博目前的股价为55.60美元,超出了分析师的预期区间。